MTLS Materialise ADS

Materialise NV Announces Results of 2025 Extraordinary Shareholders’ Meeting

Materialise NV Announces Results of 2025 Extraordinary Shareholders’ Meeting

Leuven, Belgium, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Materialise NV (NASDAQ: MTLS), a leading provider of additive manufacturing software and of sophisticated 3D printing solutions, today announced the results of the votes cast at its Extraordinary Shareholders’ Meeting, where all the proposed resolutions were approved.

For additional information, please visit:

About Materialise NV

Materialise NV incorporates more than three decades of 3D printing experience into a range of software solutions and 3D printing services that empower sustainable 3D printing applications. Our open, secure, and flexible end-to-end solutions enable flexible industrial manufacturing and mass personalization in various industries — including healthcare, automotive, aerospace, eyewear, art and design, wearables, and consumer goods. Headquartered in Belgium and with branches worldwide, Materialise NV combines the largest group of software developers in the industry with one of the world's largest and most complete 3D printing facilities.

For additional information, please visit:  



Kristof Sehmke
Materialise
EN
14/11/2025

Underlying

MTLSMaterialise ADS

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Materialise ADS

Guy Sips
  • Guy Sips
MTLS MATERIALISE ADS

Materialise Transferring RapidFit business to its management team (MBO...

Materialise announced that it will transfer its RapidFit activities to the current management team, after which RapidFit will continue as an independent company under the same name and leadership. The activities were part of Materialise's Manufacturing division, and the transaction marks another step in the group's strategy to sharpen its focus on profitable activities. As a standalone company, RapidFit will benefit from greater focus and flexibility, enabling faster decision-making, closer pr...

03/31/26 March 31, 2026 1 EN
 PRESS RELEASE
Free
MTLS MATERIALISE ADS

Materialise to Transfer RapidFit Business to Its Management Team

Materialise to Transfer RapidFit Business to Its Management Team Leuven (BELGIUM), March 31, 2026 (GLOBE NEWSWIRE) -- Materialise NV (Euronext & Nasdaq: MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, announces the decision to transfer its RapidFit business to its management team. Following the transaction, RapidFit will continue as an independent company under the ownership and leadership of the same team under the RapidFit name. The decision aligns with Materialise’s growth strategy by focusing investm...

March 31, 2026 1 EN
Guy Sips ... (+7)
  • Guy Sips
  • Hilde Van Boxstael
  • Livio Luyten
  • Mathijs Geerts Danau
  • Michiel Declercq
  • Wim Hoste
  • Wim Lewi
PROX Proximus SA de ...
MTLS MATERIALISE ADS ... (+8)

Morning Notes : ACKB BB, FAGR BB, FUR NA, MTLS US, MDXH BB, PROX BB, R...

: ACKB BB, FAGR BB, FUR NA, MTLS US, MDXH BB, PROX BB, RECT BB, WHATS BB

PROX PROXIMUS SA DE DROIT PUBLIC
MTLS MATERIALISE ADS
FAGR FAGRON SA
TERB TER BEKE N.V.
REC RECTICEL SA
ACKB ACKERMANS & VAN HAAREN NV
FUR FUGRO NV
MDXH MDXHEALTH
02/27/26 February 27, 2026 1 EN
Guy Sips
  • Guy Sips
MTLS MATERIALISE ADS

Materialise A Two-Speed Story

Materialise enters 2026 with diverging momentum across its business segments: - Medical continues to expand robustly, increasingly becoming the company's structural growth engine driven by deeper platform adoption and mass personalization. - Software is transitioning successfully toward a subscription-based, cloud-native AM workflow platform, with significant medium-term operating leverage. - Manufacturing faces persistent macro softness, particularly in European prototyping, with recovery depen...

02/27/26 February 27, 2026 1 EN
Guy Sips
  • Guy Sips
MTLS MATERIALISE ADS

Materialise FIRST LOOK : 4Q25 results

We will update our model as Materialise expects FY26 to grow to a range of €273m to €283m (KBCSe € 282.5m). Materialise will continue investing in its Materialise Medical and Software segments while maintaining disciplined cost control and optimization, in particular in its Materialise Manufacturing segment and in its overhead. As a result, Materialise expects its FY26 Adj EBIT to reach € 10m to € 12m (KBCSe € 14.5m). FY25 revenue remained stable at € 267.6m (KBCSe € 269.3m), fuelled by stron...

02/19/26 February 19, 2026 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch